Net Cash Provided by (Used in) Operating Activities |
-969K |
USD |
+19.2% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
467K |
USD |
-79% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-232K |
USD |
0% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
85M |
shares |
|
Q1 2025 |
Q1 2025 |
Common Stock, Shares, Issued |
4.32M |
shares |
|
Q1 2025 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-734K |
USD |
-193% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
21.7M |
USD |
+10.3% |
Q4 2024 |
FY 2025 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.24 |
pure |
0% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Gross |
21.7M |
USD |
+10.3% |
Q4 2024 |
FY 2025 |
Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
-100% |
Q1 2024 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
15.3M |
USD |
-2.77% |
Q4 2024 |
FY 2025 |
Unrecognized Tax Benefits |
331K |
USD |
0% |
Q1 2025 |
Q1 2025 |
Additional Paid in Capital |
139M |
USD |
+2.51% |
Q1 2025 |
Q1 2025 |
Depreciation, Depletion and Amortization |
1.04M |
USD |
-6.96% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
-100% |
Q4 2024 |
FY 2025 |
Share-based Payment Arrangement, Expense |
1.9M |
USD |
-6.6% |
Q1 2025 |
Q1 2025 |
Interest Expense |
1.75M |
USD |
+72.8% |
Q3 2024 |
Q3 2025 |